We are live on
!
Find out more
Cerity Partners Portfolio holdings
AUM
$70.8B
1-Year Est. Return
21.68%
This Fund
S&P 500
This Quarter
Est. Return
-1.45%
1 Year Est. Return
+21.68%
3 Year Est. Return
+64.34%
5 Year Est. Return
+67.23%
10 Year Est. Return
–
AUM
$49.4B
AUM Growth
+$3.27B
(+7.1%)
Cap. Flow
+$4.69B
Cap. Flow
% of AUM
9.5%
Top 10 Holdings %
Top 10 Hldgs %
24.75%
Holding
2,665
New
250
Increased
1,263
Reduced
867
Closed
191
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$282M |
| 2 |
Apple
AAPL
|
+$280M |
| 3 |
Microsoft
MSFT
|
+$202M |
| 4 |
Broadcom
AVGO
|
+$201M |
| 5 |
NVIDIA
NVDA
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$205M |
| 2 |
Bank of America
BAC
|
+$123M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$116M |
| 4 |
Intuit
INTU
|
+$84.6M |
| 5 |
Automatic Data Processing
ADP
|
+$55.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.74% |
| 2 | Financials | 8.29% |
| 3 | Healthcare | 7.21% |
| 4 | Consumer Staples | 5.36% |
| 5 | Consumer Discretionary | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Teva Pharmaceuticals
TEVA
$40.8B
| $685K | ﹤0.01% |
44,546
-3,166
| -7% | -$56.6K |
|
1602
FTI Consulting
FCN
$4.4B
| $682K | ﹤0.01% |
4,159
-2,786
| -40% | -$501K |
|
1603
Nutrien
NTR
$33.2B
| $682K | ﹤0.01% |
13,730
+2,876
| +26% | +$147K |
|
1604
AdvisorShares Focused Equity ETF
CWS
$134M
| $681K | ﹤0.01% |
10,400
-100
| -1% | -$6.62K |
|
1605
West Pharmaceutical
WST
$24B
| $679K | ﹤0.01% |
3,031
-2,353
| -44% | -$648K |
|
1606
Axos Financial
AX
$5.77B
| $677K | ﹤0.01% |
10,490
-3,851
| -27% | -$261K |
|
1607
iShares US Industrials ETF
IYJ
$1.98B
| $672K | ﹤0.01% |
5,166
-390
| -7% | -$52.9K |
|
|
DSL
1608
DoubleLine Income Solutions Fund
DSL
$1.22B
| $672K | ﹤0.01% |
53,320
-2,000
| -4% | -$25.3K |
|
1609
FT Vest S&P 500 Dividend Aristocrats Target Income ETF
KNG
$3.4B
| $672K | ﹤0.01% |
13,308
-1,432
| -10% | -$72.6K |
|
1610
Stellantis
STLA
$16.7B
| $672K | ﹤0.01% |
59,931
-27,935
| -32% | -$359K |
|
1611
Employers Holdings
EIG
$922M
| $671K | ﹤0.01% |
+13,252
| New | +$657K |
|
1612
Coupang
CPNG
$29.3B
| $670K | ﹤0.01% |
30,549
+9,042
| +42% | +$210K |
|
1613
United Natural Foods
UNFI
$3.08B
| $668K | ﹤0.01% |
24,393
-17,630
| -42% | -$511K |
|
1614
ACI Worldwide
ACIW
$5.83B
| $667K | ﹤0.01% |
12,194
+3,315
| +37% | +$176K |
|
1615
US Commodity Index
USCI
$369M
| $667K | ﹤0.01% |
9,248
| – | – |
|
|
SRTA
1616
Strata Critical Medical Inc
SRTA
$434M
| $666K | ﹤0.01% |
243,929
-378
| -0.2% | -$1.36K |
|
1617
Axsome Therapeutics
AXSM
$11.2B
| $666K | ﹤0.01% |
5,707
+766
| +16% | +$87.3K |
|
1618
Equinor
EQNR
$97.7B
| $664K | ﹤0.01% |
25,100
+1,509
| +6% | +$36.6K |
|
1619
WSFS Financial
WSFS
$4.12B
| $661K | ﹤0.01% |
+12,735
| New | +$686K |
|
1620
JPMorgan BetaBuilders Japan ETF
BBJP
$17.5B
| $660K | ﹤0.01% |
11,764
+2,395
| +26% | +$135K |
|
1621
Signet Jewelers
SIG
$3.61B
| $659K | ﹤0.01% |
11,357
+766
| +7% | +$43.9K |
|
1622
Regency Centers
REG
$14.7B
| $658K | ﹤0.01% |
8,915
+708
| +9% | +$51.5K |
|
1623
Telephone and Data Systems
TDS
$3.82B
| $656K | ﹤0.01% |
16,942
-603
| -3% | -$21.7K |
|
1624
Icon
ICLR
$12.6B
| $655K | ﹤0.01% |
3,741
-2,345
| -39% | -$455K |
|
1625
Fabrinet
FN
$15.6B
| $652K | ﹤0.01% |
3,300
+1,990
| +152% | +$434K |
|
Similar funds
Cerity Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Cerity Partners held 2,665 positions worth $49.4B, up 7.1% from $46.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Cerity Partners deployed $4.69B of net new capital in Q1 2025, opening 250 new positions and adding to 1,263 existing holdings. Its largest new stake was Ezcorp Inc: 564,555 shares worth $8.31M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Tetra Tech, an estimated $26.9M trimmed.
- Cerity Partners's largest Q1 2025 buy was Ezcorp Inc: 564,555 shares worth $8.31M.
- Cerity Partners added most to Meta Platforms (Facebook) in Q1 2025, an estimated $282M increase.
- Cerity Partners's biggest Q1 2025 reduction was Tetra Tech, cutting an estimated $26.9M.
- Cerity Partners fully exited ExxonMobil in Q1 2025, selling an estimated $205M.
- Cerity Partners's ten largest holdings make up 25% of its $49.4B portfolio in Q1 2025.
- Cerity Partners opened 250 new positions and closed 191 in Q1 2025.
- Cerity Partners's portfolio value rose 7.1% quarter-over-quarter to $49.4B.
Based on Cerity Partners's 13F filing for Q1 2025, filed 30 Apr 2025.